Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Paolini

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohortsGiovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Journal of Neurology|June 23, 2022
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's diseasePeggy Barschke, Samir Abu-Rumeileh, M H D Rami Al Shweiki, et al.
Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohortsGiovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Journal of Neurology|June 23, 2022
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's diseasePeggy Barschke, Samir Abu-Rumeileh, M H D Rami Al Shweiki, et al.
Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 6